Skip to main content

Comparison of Imipenem and Ceftazidime as Therapy for Severe Melioidosis

Breadcrumb

  1. Home /
  2. Comparison of Imipenem and Ceftazidime As Therapy For Severe Melioidosis
Home
QMRA wiki
Main navigation
  • About
  • Framework
    • Hazard Identification
    • Dose Response
    • Exposure Assessment
    • Risk Characterization
    • Risk Management
  • Pathogens
  • Resources
    • Key material
    • Case studies
    • Glossary
    • Apps

Supporting institutes:

Content is contributed by and edited by researchers of the Center for Advancing Microbial Risk Assessment (CAMRA), camra.msu.edu.

QMRAWiki 
Michigan State University, College of Engineering, Department of Biosystems and Agricultural Engineering,

524 S. Shaw Lane

East Lansing, Michigan 48824, USA

  • Phone: 517-353-4544
  • Fax: 517-432-2892

Contact information:
Dr. Jade Mitchell or Dr. Mark Weir  at qmraIII@anr.msu.edu

The QMRA Wiki is supported by Michigan State University and Ohio State University through support by the National Institute of General Medical Sciences of the National Institutes of Health Number R25GM108593 and the Homer Nowlin Chair in Water Research. The content is solely the responsibility under Award of the authors and does not necessarily represent the official views of the National Institutes of Health.

Michigan State University, College of Engineering, 2024